Clinical Trials Browser

Rectal Neoplasms

Breast Neoplasms

Rectal Neoplasms

Neoplasm, Residual, Triple Negative Breast Neoplasms

Colonic Neoplasms

Neoplasm Metastasis, Neoplasms

Anatomic Stage IV Breast Cancer AJCC v8

Nasopharyngeal Carcinoma

Pathologic Complete Response, Rectal Neoplasms

Rectal Neoplasms

Breast Neoplasms, Meningeal Neoplasms

Triple Negative Breast Neoplasms

Locally Advanced Rectal Cancer

Nasopharangeal Cancer

Anus Neoplasms

Rectal Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Locally Advanced Rectal Cancer

Breast Neoplasms

Breast Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Rectal Neoplasms

Breast Neoplasms

Rectal Neoplasms

Advanced Colorectal Cancer

Brain Neoplasms, Breast Neoplasms

Colorectal Cancer Metastatic

Biliary Tract Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Breast Neoplasms

Appendiceal Neoplasms, Neoplasm Metastasis

Brain Neoplasms, Breast Neoplasms

Stomach Neoplasms

Neuroendocrine Tumors

Breast Neoplasms

Triple Negative Breast Neoplasms

Breast Neoplasms, Head and Neck Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Cervical Esophagus Adenocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Breast Neoplasms

Colonic Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Triple Negative Breast Neoplasms

Neuroendocrine Tumors

Rectal Neoplasms

Biliary Tract Neoplasms

Anus Neoplasms

Locally Advanced Rectal Cancer

Colonic Neoplasms

Clinical Trials

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

TRIUNITE-08

EMPOWER

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study

TARMAC

SMART TNT

A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma

Adaptive Radiation in Anal Cancer

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

LAP100

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

TORCH-iTNT

CAPELA

INSIGHT

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

WW3

Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

mRCAT-E

Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer

SOLARA

Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

BRE-08

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling

Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer

CapTemY90

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

CAPPA

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

NeoCHIC

NeoADAPT

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer

START-NET

Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study

MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer

KANALRAD

Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)

The Sagittarius Trial